NTAP NF1 Research Acceleration Newsletter

Get access to – The most up to date research into plexiform and cutaneous neurofibromas

• A community of top scientists, advisors and leaders who provide guidance, insight, and priceless connections to colleagues doing related work
• Access to funding resources without bureaucratic red tape
• Rapid access to the newest research findings and what they mean

From around the world join the NTAP community because our funded initiatives have the highest likelihood of achieving breakthroughs in basic science and therapeutic outcomes.

Learn more about funding opportunities

NTAP research initiatives include bold, creative, sometimes unorthodox ideas that probe the basic aspects of tumorgenesis through clinical investigations of drugs.

The outsize volume, speed, and impact of our research into NF1 therapies is achieved in two crucial ways. First, through a level of collaboration and transparency that is unique both within and outside the field of the neurofibromatosis research community. Second, by focusing our research exclusively on plexiform and cutaneous neurofibromas, we offer researchers and pharmaceutical partners global visibility across the spectrum of needs and opportunities for developing effective therapies.

• Research findings on plexiform and cutaneous neurofibromas
• Notifications of new grant opportunities
• Access to the insights of a professional community of expert researchers and advisors across oncology, neurology, dermatology, genetics, biotech, marketing and business
• Alerts about upcoming conferences and events

Keep up with the latest research findings, news and updates in NF1. You’ll always know about breakthrough research and scientific discoveries, new funding, and upcoming conferences and events.